John Charbonneau
SVP of Investor Relations
Replay available
Core Scientific, Inc. (NASDAQ: CORZ) Q2 2026 earnings conference call, held 2026-07-28. Replay captured from the company's public earnings webcast.

SVP of Investor Relations
CEO
Chief Operating Officer
Chief Financial Officer
Analyst, Needham & Company
Analyst, Cantor Fitzgerald
Analyst, Lucid Capital
Analyst, Jefferies
Watch the replay and follow the connected company analysis, news, and investor updates for Core Scientific, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.092 Greetings and welcome to the Core Scientific Fiscal Second Quarter 2026 00:00:05.092 -- 00:00:10.413 Earnings Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.413 -- 00:00:14.614 A question and answer session will follow the formal presentation. 00:00:14.614 -- 00:00:18.955 If anyone should require operator assistance during the conference, please press star 00:00:18.955 -- 00:00:21.616 zero on your telephone keypad. 00:00:21.616 -- 00:00:23.856 Please note, this conference is being recorded. 00:00:23.856 -- 00:00:29.138 I would now like to turn the conference over to your host, John Charbonneau, SVP 00:00:29.138 -- 00:00:32.459 of Investor Relations. Please go ahead. 00:00:32.459 -- 00:00:37.880 Good morning and welcome to Core Scientific's second quarter 2026 earnings 00:00:37.880 -- 00:00:43.201 call. Before we begin, I need to remind you that statements made on this call, 00:00:43.201 -- 00:00:48.122 other than historical facts, are forward-looking statements within the meaning of the 00:00:48.122 -- 00:00:53.303 Private Securities Litigation Reform Act of 1995 00:00:53.303 -- 00:00:56.065 and are based on our current expectations. 00:00:56.065 -- 00:00:59.746 Words such as anticipates, expects, 00:00:59.746 -- 00:01:04.907 intends, believes, and similar words and expressions are intended to identify 00:01:04.907 -- 00:01:09.969 forward-looking statements. These statements are subject to risk and uncertainties that 00:01:09.969 -- 00:01:13.810 could cause actual results to differ substantially. 00:01:13.810 -- 00:01:18.871 For further information on these risks and uncertainties, we encourage you to review 00:01:18.871 -- 00:01:24.152 the risk factors discussed in the company's reports on Form...